C0002732||acetylated amylose
C0035608||rifampicin
C0002732||Amylose
C0002732||Amylose
C0450442||agents
C1704241||complexes
C0005479||biomaterial
C0013185||pharmaceutical industry
C0035608||Rifampicin
C0035608||Rifampicin
C1254351||drug
C0026926||Mycobacterium tuberculosis
C1533734||administration
C0035608||Rifampicin
C0002732||amylose
C0002732||Amylose
C1704241||complexes
C0002732||acetylated amylose
C0002732||AMA
C0043047||water
C0002732||amylose
C0002732||acetylated amylose
C0206055||Fourier Transform Infrared (FT-IR) spectroscopy
C0026020||Scanning Electron Microscopy
C0026020||Scanning Electron Microscopy
C0206055||Fourier Transform Infrared
C1444656||indicated
C0001038||acetylation
C0017725||anhydroglucose
C0002732||amylose
C0026020||Scanning Electron Microscopy
C0205148||smooth surfaces
C0002732||amylose
C0205148||surfaces
C0001038||acetylation
C0936012||analysis
C0002732||Amylose
C0035608||Rifampicin
C0002732||AMA
C0035608||Rifampicin
C0002732||amylose
C1882368||dynamic light scattering
C1882368||dynamic light scattering
C0456389||average size
C1882368||dynamic light scattering
C0936012||analysis
C1704241||complexes
C0150312||presence
C0035608||Rifampicin
C0002732||amylose
C1517331||further
C0085104||drug delivery systems